Monoclonal antibody resistant to human phosphodiesterase 4D interaction protein variant 5 and application thereof
A technology of human phosphodiesterase and monoclonal antibody, applied in the direction of anti-animal/human immunoglobulin, microbial-based methods, biochemical equipment and methods, etc., can solve problems such as incomplete clarification of the relationship
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0018] The present invention will be described in detail below in conjunction with the accompanying drawings and embodiments.
[0019] 1. Preparation of monoclonal antibody against Myomegalin variant 5 (phosphodiesterase 4D interacting protein variant 5)
[0020] 1. Source of experimental materials
[0021] BALB / c mice were provided by Tianjin Cancer Hospital and purchased from Beijing Weitong Lihua Experimental Animal Technology Co., Ltd.; Hela cells and mouse myeloma cells (SP2 / 0) were provided by Tianjin Cancer Hospital and purchased from Institute of Hematology, Chinese Academy of Sciences. Freund's complete adjuvant and incomplete Freund's adjuvant, HAT, and HT conditioned medium components were purchased from Invitrigen. DMEM medium, polyethylene glycol (PEG), and RPMI 1640 medium were purchased from Hyclone Company. Horseradish peroxidase (HRP)-labeled goat anti-mouse Ig, o-phenylenediamine (OPD), diaminobenzidine (DAB), and 8-azaguanine (8-AG) were purchased from Sig...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 